Atlas Trials

Soluble Neprilysin, NT-proBNP, and Growth-Differentiation-Factor-15 as Biomarkers for Heart Failure in Dialysis Patients

Clinical trial NCT04061811 · COMPLETED

Trial details

NCT number
NCT04061811
Sponsor
Hannover Medical School
Status
COMPLETED
Study type
OBSERVATIONAL
Heart FailureEnd Stage Renal Disease
Start date
2018-08-01
Primary completion
2019-02-28
Enrollment
153

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.